Serum Adiponectin Relates to Shortened Overall Survival in Men with Squamous Cell Esophageal Cancer Treated with Preoperative Concurrent Chemoradiotherapy: A Pilot Study
暂无分享,去创建一个
L. Petruzelka | B. Staňková | M. Zeman | M. Zemanova | A. Pazdro | E. Tvrzická | Zuzana Ušiaková | L. Petruželka
[1] A. Sonnenberg,et al. Risk Factors in the Development of Esophageal Adenocarcinoma , 2013, The American Journal of Gastroenterology.
[2] G. Lippi,et al. The role of resistin in colorectal cancer. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[3] M. Zemanova,et al. Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors. , 2012, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[4] D. Fang,et al. MicroRNA and its roles in esophageal cancer , 2012, Medical science monitor : international medical journal of experimental and clinical research.
[5] K. Lee,et al. Pathophysiological Role of Hormones and Cytokines in Cancer Cachexia , 2012, Journal of Korean medical science.
[6] PhD Christophe Mariette MD,et al. Surgery in Esophageal and Gastric Cancer Patients: What is the Role for Nutrition Support in your Daily Practice? , 2012, Annals of Surgical Oncology.
[7] I. Ulman-Włodarz,et al. Adiponectin to leptin index as a marker of endometrial cancer in postmenopausal women with abnormal vaginal bleeding: an observational study. , 2012, Neuro endocrinology letters.
[8] V. Tutino,et al. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. , 2011, Anticancer research.
[9] Mary T. Brinkoetter,et al. Leptin in human physiology and pathophysiology. , 2011, American journal of physiology. Endocrinology and metabolism.
[10] L. Feldman,et al. IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[11] A. Vasku,et al. Relationship of resistin levels with endometrial cancer risk. , 2011, Neoplasma.
[12] T. Zima,et al. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. , 2011, Neoplasma.
[13] M. Wong,et al. Associations between adipokines and obesity-related cancer. , 2011, Frontiers in bioscience.
[14] D. Gupta,et al. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature , 2010, Nutrition journal.
[15] Qian-chun Yu,et al. Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. , 2010, Gastroenterology.
[16] B. Melichar,et al. Prognostic factors in patients with esophageal carcinoma treated with chemoradiation: single center experience. , 2010, Hepato-gastroenterology.
[17] E. Nowakowska-Zajdel,et al. Leptin and its receptors in obese patients with colorectal cancer. , 2010, Journal of biological regulators and homeostatic agents.
[18] T. Matsuda,et al. Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer , 2010, Cancer science.
[19] H. Takeda,et al. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. , 2010, World journal of gastroenterology.
[20] Chien‐An Sun,et al. Adipocytokine resistin and breast cancer risk , 2010, Breast Cancer Research and Treatment.
[21] L. Petruzelka,et al. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. , 2010, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[22] T. Lawrence,et al. The resolution of inflammation and cancer. , 2010, Cytokine & growth factor reviews.
[23] M. Stampfer,et al. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. , 2010, Clinical chemistry.
[24] I. Oda,et al. Adipocytokines and squamous cell carcinoma of the esophagus , 2010, Journal of Cancer Research and Clinical Oncology.
[25] Yan Wang,et al. Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma , 2009, Lipids in Health and Disease.
[26] C. Mantzoros,et al. Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D G Altman,et al. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond , 2009, British Journal of Cancer.
[28] Serap Yıldırım,et al. Serum adiponectin levels in patients with esophageal cancer. , 2008, Japanese journal of clinical oncology.
[29] T. Krechler,et al. Polymorphism -23HPhI in the promoter of insulin gene and pancreatic cancer: a pilot study. , 2009, Neoplasma.
[30] M. Sok,et al. Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer , 2009, Wiener klinische Wochenschrift.
[31] C. Mantzoros,et al. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case–control study , 2009, Cancer Causes & Control.
[32] C. Mantzoros,et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study , 2009, Cancer Causes & Control.
[33] E. Karapanagiotou,et al. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). , 2008, Lung cancer.
[34] H. Parving,et al. Elevated levels of high-molecular-weight adiponectin in type 1 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.
[35] G. Fantuzzi. Adiponectin and inflammation: consensus and controversy. , 2008, The Journal of allergy and clinical immunology.
[36] M. Lazar,et al. Adipokines and the peripheral and neural control of energy balance. , 2008, Molecular endocrinology.
[37] T. Kadowaki,et al. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS , 2008, FEBS letters.
[38] C. Mantzoros,et al. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. , 2007, The American journal of clinical nutrition.
[39] D. Rose,et al. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. , 2007, Endocrine-related cancer.
[40] Val Gebski,et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.
[41] V. Gebski,et al. AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP. SURVIVAL BENEFI TS FROM NEOADJUVANT CHEMORADIOTHERAPY OR CHEMOTHERAPY IN OESOPHAGEAL CARCINOMA: A META-ANALYSIS , 2007 .
[42] S. Jee,et al. White Blood Cell Count and the Risk of Colon Cancer , 2006, Yonsei medical journal.
[43] E. Surmacz,et al. Leptin and cancer , 2006, Journal of cellular physiology.
[44] I. Shimon,et al. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients , 2006, Cancer.
[45] H. Nagawa,et al. Plasma adiponectin and gastric cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[46] T. Erlinger,et al. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[47] M. Coleman,et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[48] K. Cianflone,et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.
[49] J. Bełtowski. Adiponectin and resistin--new hormones of white adipose tissue. , 2003, Medical science monitor : international medical journal of experimental and clinical research.
[50] C. McArdle,et al. Systemic inflammatory response predicts survival following curative resection of colorectal cancer , 2003, The British journal of surgery.
[51] Joanna D. Holbrook,et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .
[52] Cai Li,et al. Generation of Soluble Leptin Receptor by Ectodomain Shedding of Membrane-spanning Receptors in Vitro and in Vivo * , 2002, The Journal of Biological Chemistry.
[53] A. Ozet,et al. Low Serum Leptin Level in Colon Cancer Patients without Significant Weight Loss , 2002, Tumori.
[54] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[55] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.